TERNS PHARMACEUTICALS INC Share Price Today: Live Updates & Key Insights
TERNS PHARMACEUTICALS INC share price today is $48.52, up -1.26%. The stock opened at $48.34 against the previous close of $49.06, with an intraday high of $49.79 and low of $47.98.
TERNS PHARMACEUTICALS INC Share Price Chart
TERNS PHARMACEUTICALS INC
TERNS PHARMACEUTICALS INC Share Price Performance
TERNS PHARMACEUTICALS INC Institutional Holdings
TERNS PHARMACEUTICALS INC Market Status
TERNS PHARMACEUTICALS INC Fundamentals
Market Cap 5268.69 M
PB Ratio 18.6048
PE Ratio 0.0
Enterprise Value 4990.40 M
Total Assets 363.93 M
Volume 4863348
TERNS PHARMACEUTICALS INC Company Financials
About TERNS PHARMACEUTICALS INC & investment objective
Company Information Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.
Organisation Biotechnology
Employees 59
Industry Biotechnology
CEO Ms. Amy L. Burroughs M.B.A.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
TERNS PHARMACEUTICALS INC FAQs
What is the share price of TERNS PHARMACEUTICALS INC today?
The current share price of TERNS PHARMACEUTICALS INC is $48.52.
Can I buy TERNS PHARMACEUTICALS INC shares in India?
Yes, Indian investors can buy TERNS PHARMACEUTICALS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy TERNS PHARMACEUTICALS INC shares in India?
You can easily invest in TERNS PHARMACEUTICALS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy TERNS PHARMACEUTICALS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of TERNS PHARMACEUTICALS INC.
Can I buy fractional shares of TERNS PHARMACEUTICALS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of TERNS PHARMACEUTICALS INC?
TERNS PHARMACEUTICALS INC has a market cap of $5268.69 M.
In which sector does TERNS PHARMACEUTICALS INC belong?
TERNS PHARMACEUTICALS INC operates in the Biotechnology sector.
What documents are required to invest in TERNS PHARMACEUTICALS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of TERNS PHARMACEUTICALS INC?
The PE ratio of TERNS PHARMACEUTICALS INC is N/A and the PB ratio is 18.60.